Clinical development summary

Our pipeline currently consists of:

  • Two lead product candidates for the treatment of sight-threatening retinal degenerative diseases, together with
  • Products in preclinical development targeting ophthalmic and neurodegenerative diseases

Visit www.clinicaltrials.gov and search for “GenSight Biologics” to learn more about our ongoing clinical trials listed below.

Our products